Artal Group S.A. Alpine Immune Sciences, Inc. Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.75 - $41.6 $6.3 Million - $14.8 Million	355,025 Added 699.43%	405,784 $16.1 Million
Q4 2023 Feb 09, 2024	SELL	$8.54 - $20.22 $9.75 Million - $23.1 Million	-1,142,271 Reduced 95.75%	50,759 $967,000
Q3 2022 Nov 14, 2022	BUY	$6.89 - $9.39 $4.13 Million - $5.63 Million	600,000 Added 101.18%	1,193,030 $8.59 Million
Q3 2020 Nov 13, 2020	BUY	$7.15 - $11.5 $4.24 Million - $6.82 Million	593,030 New	593,030 $5.21 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.